Companies / Coya Therapeutics, Inc.

Coya Therapeutics, Inc.

Nasdaq: COYACIK 1835022HOUSTON, TX

Financials · FY2025

Revenue$7.95M
Net income$-21.23M
Total debt—
Cash$43.18M
Diluted EPS$-1.27
Shares outstanding23.5M

Ownership

23.5M shares outstanding · as of Aug 7, 2026
8.6%10%+ / strategic
Ownership
10%+ / strategic8.56%2,007,311
Institutions29.69%6,965,744
Public float61.75%14,484,794

% of common shares outstanding (exact, from the latest cover-page filing). Institutions are quarterly 13F snapshots; insiders reflect current officers & directors.

Insiders 10

View all →
Insider% of sharesShares
Berman HowardExecutive Chairman · Director
——
Goldstein Dov a MdDirector
——
Grossman FredChief Medical Officer
——
Lee AnnDirector
——
Pavao Mark HDirector
——
Ross Wilbur L JrDirector
——
Snyder David SChief Financial Officer
——
Swaminathan ArunCEOChief Executive Officer · Director
——
Villalobos AnabellaDirector
——
Weinand DieterDirector
——

Institutional holders 61

View all →
HolderValue% of shares
DME Capital Management, LP$11.75M8.64%
Vanguard Group Inc$5.22M3.83%
Alyeska Investment Group, L.P.$4.64M3.41%
AWM Investment Company, Inc.$4.21M3.09%
AIGH Capital Management LLC$3.70M2.69%
CM Management, LLC$2.03M1.49%
Private Management Group Inc$1.45M1.57%
Geode Capital Management, LLC$919.8K0.99%
Marshall Wace, LLP$889.6K0.96%
Susquehanna International Group, LLP$724.0K0.53%

Activity

View all →
InsidersInstitutions
What insiders are doing in this stock (Form 4).
DateActorActionSecurityValueShares ΔPosition afterImpact
Apr 9, 2026Pavao Mark H
Director
GrantStock Option (right to buy)—+10K
10,000
0.04% of shares
low
Jan 22, 2026Snyder David S
Executive
GrantStock Option (right to buy)—+140K
140,041
0.60% of shares
low
Jan 22, 2026Grossman Fred
Executive
GrantStock Option (right to buy)—+140K
140,041
0.60% of shares
low
Jan 22, 2026Berman Howard
Executive
GrantStock Option (right to buy)—+15K
15,257
0.07% of shares
low
Jan 22, 2026Swaminathan Arun
CEO
GrantStock Option (right to buy)—+294K
293,983
1.25% of shares
low
Jan 2, 2026Villalobos Anabella
Director
GrantStock Option (right to buy)—+10K
10,000
0.04% of shares
low
Jan 2, 2026Goldstein Dov a Md
Director
GrantStock Option (right to buy)—+10K
10,000
0.04% of shares
low
Jan 2, 2026Weinand Dieter
Director
GrantStock Option (right to buy)—+10K
10,000
0.04% of shares
low

5%+ ownership events

Schedule 13D / 13G
FilerStance% of classSharesDate
Vanguard Group IncPassive13G/A—899,140—
Orin HirschmanPassive13G/A—1,108,171—
Dr. Reddy's Laboratories, Inc.Passive13G———

Securities

via CUSIP / OpenFIGI
SymbolTypeMarketCUSIPFIGI
COYACommon StockEquity22407B108BBG00Z4HBCB9